COOK MEDICAL introduces its Evolution® Esophageal Fully Covered Controlled-Release Stent, which is designed to improve quality of life for patients with malignant esophageal strictures and tracheoesophageal fistulas(TEF) by improving the patients’ ability to swallow, and its silicone that fully covers the stent helps prevent tumor ingrowth. In addition, the system gives physicians unparalleled control during stent deployment and recapture.
The Evolution® Controlled Release Esophageal Fully Covered Stent is used to maintain patency of malignant esophageal strictures and/or to seal tracheoesophageal fistulas.
*Silicone-encased stent reduces the risk of tumor ingrowth and food impaction.
*Silicone coating throughout the length of each stent is designed to enhance treatment of malignant esophageal TE fistulas.
*Dual lasso loops for proximal and distal stent repositioning immediately after placement.
*Proximal and distal flanges reduce the risk of stent migration.
*Proportional length of stent deployed or recaptured with each trigger squeeze for precise placement.
*Supplied sterile. Disposable; intended for single use only.
About this company:
A global pioneer in medical breakthroughs, Cook Medical is committed to creating effective solutions that benefit millions of patients worldwide. Today, we combine medical devices, drugs, biologic grafts and cell therapies across more than 16,000 products serving more than 40 medical specialties. Founded in 1963 by a visionary who put patient needs and ethical business practices first, Cook is a family-owned company that has created more than 10,000 jobs worldwide.
COOK MEDICAL INC.
750 Daniels Way
Note: The copyright and the ownship of the brand, product names, product numbers, and content mentioned belongs to their repective companies.